Our mission is to democratize access to advanced cancer treatment. We empower patients to own their cancer journey with our AI-powered decision support platform. Our SaaS intelligence platform discovers barriers between Pharma and patient to expedite time to market and reduce costs.

Our Story​

Tzvia Bader, CEO and co-founder

“In December 2013 I was diagnosed with Malignant Melanoma. This came almost 20 years after I lost my mom to Non-Hodgkins Lymphoma. With three young daughters at home who need me, losing this battle is not an option. After participating in three clinical trials, I’ve been in remission for four years.

I quickly learned throughout this process that the way in which patients gain access to advanced treatments through clinical trials is completely broken. 

Understanding ALL treatment options is critical for people to own their cancer journey, as I have been fortunate enough to do. After spending 20 years building technology companies, it is clear  that AI offers the only viable path to empowering every individual on the planet with the knowledge and tools they need to receive the best treatment possible.”


Management Team

Tzvia Bader

Tzvia Bader

Noam Geva Head of Product

Noam Geva
Head of Product

Avital Gaziel Head of Medical Affairs

Avital Gaziel
Head of Medical Affairs

Guy Gildor CTO

Guy Gildor

Noam Barnea Head of R&D

Noam Barnea
Head of R&D

Rita Tochner Head of Operations

Rita Tochner
Head of Operations

Advisors ​

Dr. Leonard Lichtenfeld, MD

Dr. Leonard Lichtenfeld, MD
Former Chief Medical and Scientific Officer 
American Cancer Society

Dr. Robert Winkler, MD

Dr. Robert Winkler, MD
Chief Medical Officer
Zentalis Pharmaceuticals

Huw Griffiths

Huw Griffiths
Global Chief Product Officer
Universal McCann